 Home > Active Ingredient News > Antitumor Therapy > The State Food and Drug Administration approves the marketing of Donafinil tosylate tablets

The State Food and Drug Administration approves the marketing of Donafinil tosylate tablets

 Last Update: 2021-06-20
 Source: Internet
 Author: User

Tags

miralax class

effexor drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 9, the official website of the State Food and Drug Administration announced that the State Food and Drug Administration recently passed the priority review and approval procedure to approve the Class 1 innovative drug Donafenib Tosylate (trade name:) declared by Suzhou Zejing Biopharmaceutical Co.

Donafenib (Donafenib) is a multi-kinase inhibitor class of small molecule anti-tumor drugs

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.